• VX-745: Practical p38α MAPK Assay Guide

  2026-08-13

  This scenario-based guide explains how VX-745, SKU A8686, can support interpretable cell viability, proliferation, cytotoxicity, and cytokine assays. It connects documented p38α selectivity and formulation characteristics with practical controls, dosing logic, and evidence-aware data interpretation.

• Nadolol (SQ-11725): A Transporter-Aware Assay Guide

  2026-08-12

  Nadolol (SQ-11725) is a non-selective beta-adrenergic antagonist for designing rigorous cardiovascular assays. This guide adds a transporter-aware pharmacokinetic framework, using disease-state tissue distribution research to improve interpretation beyond receptor pharmacology alone.

• Acetylspiramycin for Resistance Research

  2026-08-12

  Acetylspiramycin (Spiramycin B) provides a practical comparator for studying macrolide-resistant Mycoplasma pneumoniae and ribosome-directed antibacterial activity. This guide translates recent Beijing surveillance findings into reproducible susceptibility workflows, formulation controls, and troubleshooting strategies while separating MIC evidence from clinical conclusions.

• Azilsartan in Astrocyte–Microglia Assays

  2026-08-11

  Azilsartan and TAK-536 provide a precise pharmacological entry point for studying AT1 signaling beyond blood-pressure biology. This guide translates the gastrodin–RAS–SIRT3 study into practical assay design, formulation, controls, and interpretation strategies for neuroinflammation research.

• ER Stress and Intestinal Stem Cell Loss

  2026-08-10

  The reference study links tunicamycin-induced endoplasmic reticulum stress to intestinal stem-cell depletion, impaired epithelial differentiation, reduced crypt proliferation, and increased apoptosis in mice. Its central contribution is a mechanistic model in which GRP78/ATF6/CHOP activation and suppression of p44/42 MAPK signaling connect ER stress with intestinal mucosal injury.

• Viral RIPK3 Degradation in Orthopoxvirus Inflammation

  2026-08-09

  The reference study identifies a viral inducer of RIPK3 degradation, or vIRD, that hijacks the host SCF ubiquitin ligase machinery to suppress necroptosis. By combining genetic, biochemical, virological, and mouse experiments, the authors show that vIRD controls orthopoxvirus replication, inflammation, and disease severity through the RIPK3–MLKL pathway.

• CD38 CAR Binder Structures and Affinity Tuning

  2026-08-08

  Cheng et al. structurally and functionally distinguish how the CD38 CAR binders RP02 and 028 engage the antigen, inhibit its enzymatic activity, and influence CAR-T behavior. The study shows that rational affinity attenuation of 028 can reduce fratricide while preserving antitumor cytotoxicity, offering a structure-guided framework for balancing potency, selectivity, and safety.

• U-73122 Workflows for PLC Signaling and Invasion

  2026-08-07

  U-73122 is a practical phospholipase C inhibitor for connecting PLC activity with calcium flux, neutrophil chemotaxis, and cancer-cell invasion. This guide combines concentration planning, assay workflows, reference-driven interpretation, and troubleshooting for more reproducible PLC signaling pathway modulation.

• Cycloheximide: Protein Biosynthesis Inhibitor in Advanced As

  2026-08-07

  Cycloheximide (APExBIO, SKU A8244) is a best-in-class protein biosynthesis inhibitor, empowering apoptosis studies, protein turnover assays, and precise translational control in cell and animal models. This guide integrates new insights from viral export research and delivers actionable optimization tips, workflow enhancements, and troubleshooting strategies for advanced research needs.

• Ceruletide in Pancreatic Function Research: Advanced Protoco

  2026-08-06

  Ceruletide (Caerulein) is the gold-standard tool for modeling pancreatic fibrosis and gastrointestinal physiology, enabling reproducible, high-impact studies. This article translates recent mechanistic advances and practical troubleshooting tips into actionable workflows for digestive disorder research teams.

• NS1-Driven DNMT1 Degradation Controls HBoV1 Replication and

  2026-08-06

  This study uncovers how human bocavirus 1 (HBoV1) exploits host DNA methylation pathways for its replication, with the viral NS1 protein targeting DNMT1 for proteasomal degradation. The findings establish a dual regulatory role for DNMT1 in promoting viral DNA synthesis while repressing RNA processing, offering new insight into epigenetic control points relevant to antiviral research.

• Acetylcysteine in 3D Tumor Microenvironment Modeling

  2026-08-05

  Explore how Acetylcysteine (N-acetyl-L-cysteine) advances 3D tumor microenvironment models by modulating oxidative stress pathways and chemoresistance. Gain a unique systems-level perspective on assay design and translational research opportunities.

• Tofacitinib (CP-690550): Redefining Immune Metabolic Modulat

  2026-08-05

  Explore how Tofacitinib (CP-690550) uniquely bridges immune modulation and cellular metabolism—delivering advanced insight into cytokine signaling blockade and mitochondrial repair research. This article offers expert analysis distinct from existing content.

• SGC-CBP30: Selective CREBBP/EP300 Bromodomain Inhibitor Insi

  2026-08-04

  SGC-CBP30 is a potent, selective CREBBP/EP300 bromodomain inhibitor validated for epigenetics research and cancer biology. Robust evidence demonstrates its utility in dissecting transcriptional coactivator functions, particularly in early-stage lung adenocarcinoma models. This article clarifies SGC-CBP30’s mechanism, application limits, and integration into advanced workflows.

• 3-Aminobenzamide (PARP-IN-1): Applied Workflows for PARP Inh

  2026-08-04

  3-Aminobenzamide (PARP-IN-1) enables precise and reproducible poly (ADP-ribose) polymerase inhibition across cardiovascular, metabolic, and host-pathogen research models. This article delivers protocol-driven insights, troubleshooting strategies, and translational perspectives, highlighting how APExBIO’s formulation stands out for both reliability and experimental versatility.

449 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page